Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BioChemics Awarded Patent for Development of Bifunctional Synthetic Molecules

Published: Thursday, January 31, 2013
Last Updated: Thursday, January 31, 2013
Bookmark and Share
A novel drug delivery and efficacy enhancement technology.

BioChemics announced today that it has received a patent for a new breakthrough drug delivery technology. This technology called Bifunctional Synthetic Molecule, or BSM, involves covalently bonding two existing different molecules together to create a unique, new and chemically-stable molecule which contains desired physicochemical properties for the purpose of enhanced dermal, or other tissue, penetration. BSM also provides co-localization of the different components of the new molecule in the target tissue at the same time, further enhancing efficacy of the drug.

These new molecules allow BioChemics to create new chemical entities (NCE’s) with bifunctional characteristics that are, in some examples, designed to have superior tissue penetration properties and tissue targeting properties. In other examples, the BSM is designed to have a covalent bond that is both tissue-specific and enzyme-labile that releases the different functionalities of the BSM once it is deposited at the target tissue. The multiple functionalities, impacting the target tissue simultaneously, boosts efficacy and enhances disease therapy. We believe that this technology gives BioChemics the potential to re-engineer many existing drugs creating new classes of pharmaceutical agents that have an enhanced efficacy, enhanced pharmacology, and improved safety profiles. The BSM technology is designed to enhance the delivery of drugs and to improve the therapeutic index of the drug by promoting the optimal tissue distribution for maximum therapeutic impact.

“I am excited that we have been awarded this new technology,” said John Masiz, President of BioChemics Inc. “This technology may allow us to create ‘smart drugs’ that have the ability to find the specific diseased tissue target in the body and then concentrate the active drug into that specific tissue for a better therapeutic event. Further, this technology may minimize side effects since non-targeted tissue will not be impacted. This new system continues to build on BioChemics’ predecessor VALE technology and further confirms that advances in drug delivery will be the major source of pharmaceutical advancement over the next decade.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Early Genetic Changes in Premalignant Colorectal Tissue Identified
Findings point to drivers of early cancer development, targets for cancer prevention therapies.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Breakthrough Approach to Breast Cancer Treatment
Scripps scientists have designed a drug candidate that decreases growth of breast cancer cells.
A Guide to CRISPR Gene Activation
A comparison of synthetic gene-activating Cas9 proteins can help guide research and development of therapeutic approaches.
Testing Non-Breast/Ovarian Cancer Genes
Researchers have found that expanding gene panel beyond breast/ovarian cancer genes in these patients does not add any clinical benefit. Instead, testing has produced more questions than answers.
Myeloid-Derived Suppressor Cells Play Role in Tumor Growth
Researchers at Baylor College of Medicine have reported a new mechanism that helps cancer cells engage myeloid-derived suppressor cells.
Cancer Cells Coordinate to Form Roving Clusters
Rice University scientists identify ‘smoking gun’ in metastasis of hybrid cells.
Poliovirus Therapy Wins 'Breakthrough' Status
FDA decision will fast-track research on breakthrough Duke brain cancer therapy.
Novel Way to Prevent Deadly Bacterial Infections
Monash scientists may have found a way to stop deadly bacteria from infecting patients. The discovery could lead to a whole new way of treating antibiotic-resistant “superbugs”
New Treatment for Pancreatic Cancer
Researchers at Purdue University have shown how controlling cholesterol metabolism in pancreatic cancer cells reduces metastasis.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!